不同峰值管电压设置对平扫CT肾上腺腺瘤衰减的影响
该回顾性观察性队列纳入89例患者共107个影像定义的肾上腺腺瘤,分析275次平扫腹部CT,比较100、110、140 kVp与标准120 kVp下腺瘤衰减值;100 kVp下腺瘤中位衰减值显著低于120 kVp,而110与140 kVp较120 kVp无统计学显著差异。
要点
- 100 kVp下肾上腺腺瘤中位衰减值显著低于120 kVp,阅片测值需结合管电压条件解读。
- 110 kVp与140 kVp下腺瘤衰减值与120 kVp无统计学显著差异。
- 两名阅片者间衰减测量一致性极好(ICC 0.95,CI 92-97)。
核心结论
- 平扫CT采用100 kVp采集时,肾上腺腺瘤衰减值显著低于标准120 kVp采集。
- 作者指出该差异可能用于提高平扫CT对腺瘤鉴别的敏感度,但尚需纳入非腺瘤病变的进一步研究证实。
研究设计与样本
- 经IRB批准的回顾性观察性队列研究,纳入89例患者共107个影像定义的肾上腺腺瘤(最短径>6 mm,最大径均值17±6 mm,每例1-4个)。
- 纳入患者均接受两次及以上平扫腹部CT且至少使用两种不同峰值管电压设置,共分析275次CT(每例3.1±0.9次)。
- 两名阅片者独立在3 mm厚轴位MPR重建图像上绘制圆形ROI(覆盖病灶表面至少2/3)测量腺瘤衰减值,取两人均值进一步分析。
- 以120 kVp采集为参照,用Bland-Altman分析比较100、110、140 kVp采集的衰减值,并以ICC评估阅片者间变异。
诊断标准与关键数值
- 腺瘤中位衰减值100 kVp为-1 HU(IQR -5至3.6),120 kVp为2.5 HU(IQR -1.5至8.5),100 kVp显著低于120 kVp(p<0.001)。
- 110 kVp及140 kVp与120 kVp之间腺瘤衰减值差异无统计学意义。
- 阅片者间衰减测量一致性ICC为0.95(CI 92-97)。
- 腺瘤纳入标准为影像定义且最短直径>6 mm;ROI为覆盖病灶表面至少2/3的圆形ROI。
临床应用与阅片要点
- 阅片测量肾上腺腺瘤平扫衰减值时,需注意采集所用的峰值管电压,100 kVp下测值可能低于120 kVp。
- 作者认为100 kVp下衰减值较低可能被用于提高平扫CT鉴别腺瘤的敏感度,但需纳入非腺瘤病变的进一步研究证实。
局限性
- 作者指出需纳入非腺瘤病变的进一步研究来证实100 kVp提高平扫CT腺瘤鉴别敏感度的假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the influence of peak tube voltage peak setting on adrenal adenomas (AA) attenuation on unenhanced abdominal CT.
MATERIALS AND METHODS: IRB-approved retrospective observational cohort study. We included 89 patients with imaging-defined AAs with shortest diameter > 6 mm who underwent two or more unenhanced abdominal CTs using at least two different peak tube voltage settings. Two readers independently measured adenoma attenuation on different CT acquisitions by drawing a round ROI on 3 mm thick axial MPR reconstructions encompassing at least 2/3 of the lesion's surface. The mean of the values measured by the two readers was used for further analysis. Interobserver variability was assessed (Intraclass Correlation Coefficient). Attenuation values measured on 100, 110 and 140 kVp acquisitions were compared with standard 120 kVp ones (Bland-Altman analysis).
RESULTS: We included 275 unenhanced abdominal CTs (3.1 ± 0.9/patient) in image analysis; 131 acquired at 120 kVp, 65 at 100 kVp, 59 at 110 kVp, and 20 at 140 kVp. 107 lesions were detected in 89 patients (1-4/patient), with a mean maximum diameter of 17 ± 6 mm. Interobserver agreement in attenuation measurement was excellent (ICC: 0.95, CI (92-97)). Median adenoma attenuation was significantly lower on 100 kVp images than on 120 kVp ones (-1 HU, IQR (-5 to 3.6), vs, 2.5 HU, IQR (-1.5 to 8.5); p < 0.001) whereas we didn't find statistically significant differences in adenoma attenuation between 110 kVp or 140 kVp and 120 kVp ones.
CONCLUSION: AA attenuation is significantly lower on unenhanced CT scans acquired at 100 kVp than on those acquired at "standard" 120 kVp.
CLINICAL RELEVANCE STATEMENT: AA attenuation is significantly lower at 100 kVp in comparison to 120 kVp. This might be exploited to increase unenhanced CT sensitivity in adenoma characterisation, but further studies including non-adenoma lesions are mandatory to confirm this hypothesis.
KEY POINTS: CT scans are often acquired using peak tube voltage settings different from the "standard" 120 kVp. AA attenuation varies if CT scans are acquired using different tube peak voltage settings. At 100 kVp AAs show a significantly lower attenuation than at 120 kVp.
引用
- Bonatti M, Valletta R, Corato V, et al. Impact of different peak tube voltage settings on adrenal adenomas attenuation at unenhanced CT. Eur Radiol. 2024. PMID: 39068376. doi:10.1007/s00330-024-10984-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。